
Celldex Therapeutics CLDX
$ 26.48
2.16%
Quarterly report 2025-Q3
added 11-10-2025
Celldex Therapeutics DPO Ratio 2011-2026 | CLDX
Annual DPO Ratio Celldex Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.17 K | 4.16 K | 8.34 K | 4.15 K | 2.03 K | - | - | - | - | - | - | 351 | 25.2 | 37.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.34 K | 25.2 | 3.16 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.97 | 0.81 % | $ 5.29 M | ||
|
Biogen
BIIB
|
65.4 | $ 172.5 | 0.53 % | $ 25.1 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 12.1 | -5.47 % | $ 797 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Cellectis S.A.
CLLS
|
975 | $ 4.16 | -5.88 % | $ 116 M | ||
|
BioXcel Therapeutics
BTAI
|
2.52 K | $ 1.79 | -1.92 % | $ 4.54 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Compugen Ltd.
CGEN
|
123 | $ 2.05 | -2.15 % | $ 184 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 26.4 | 1.85 % | $ 1.28 B | ||
|
Coherus BioSciences
CHRS
|
53.7 | $ 2.27 | 10.19 % | $ 214 M | ||
|
Amneal Pharmaceuticals
AMRX
|
21.1 | $ 13.54 | 1.12 % | $ 4.18 B | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.73 | 1.11 % | $ 17.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 94.12 | 1.25 % | $ 96.9 B | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B |